Wordt geladen...
Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib
The therapeutic options for hepatocellular carcinoma (HCC) have been so far rather inadequate. Sorafenib has shown an overall survival benefit and has become the new standard of care for advanced HCC. Nevertheless, in clinical practice, some patients are discontinuing this drug because of side effec...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Co., Limited
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3103800/ https://ncbi.nlm.nih.gov/pubmed/21633647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i19.2450 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|